If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBarratt Redrow Regulatory News (BTRW)

Share Price Information for Barratt Redrow (BTRW)

Share Price is delayed by 15 minutes
Get Live Data
279.70    -0.30 (-0.11%)
Bid:
279.00
Ask:
279.20
Spread: 0.20 (0.072%)
Market Cap: £3.92b
BTRW Live PriceLast checked at - London Stock Exchange

Intraday Barratt Redrow Share Chart

Barratt Redrow plc ShareBuyback Programme

15 Jul 2025 07:01

RNS Number : 0161R
Barratt Redrow PLC
15 July 2025
Β 

Β 

Β 

BARRATT REDROW PLC

Share Buyback Programme

Β 

Β 

15 July 2025

Β 

Β 

In its Trading Statement earlier today, Barratt Redrow plc (the "Company") announced, in compliance with the EU and UK Market Abuse Regulations, that it will implement a programme to repurchase its ordinary shares of 10 pence each (the "Shares") up to the value of Β£100 million in total (excluding expenses) to be completed no later than 30 June 2026 (the "Programme").

Β 

The Company has entered into an agreement with Barclays Bank PLC, acting through its investment bank ("Barclays"), under which it has issued instructions to Barclays to purchase up to Β£50 million (excluding expenses) of Shares during the period commencing 15 July 2025 and to be completed no later than 31 December 2025 (the "First Tranche"). Barclays will carry out the Company's instructions through the acquisition of the Shares in the Company for subsequent repurchase by the Company. For the avoidance of doubt, no repurchases will be made in respect of the Company's American Depositary Receipts.

Β 

The purpose of the First Tranche is to reduce the capital of the Company, and it intends that the Shares purchased will be cancelled.

Β 

Any share purchases will be made by the Company within certain pre-set parameters and in accordance with the general authority of the Company to repurchase shares granted by shareholders at the Company's Annual General Meeting held on 23 October 2024 which, taking into account shares purchased subsequent to this meeting, permits the Company to purchase no more than 133,819,331 ordinary shares. Any share purchases effected by the Company will be in accordance with the EU and UK Market Abuse Regulations and UKLR 9.

Β 

Barratt Redrow plc

Mike Scott, Chief Financial Officer 01530 278 278

John Messenger, Group Investor Relations Director 07867 201 763

Β 

Media enquiries

Tim Collins, Group Corporate Affairs Director 01530 278 278

Β 

Brunswick

Jonathan Glass / Rosie Oddy 020 7404 5959

Β 

Barratt Redrow plc LEI: 2138006R85VEOF5YNK29

Β 

Β 

Β 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
Β 
END
Β 
Β 
MSCEAEXLFALSEAA
Date   Source Headline
16th Jul 20257:00 amRNSTransaction in Own Shares
15th Jul 20253:40 pmRNSDirector/PDMR Shareholding
15th Jul 202512:17 pmRNSHolding(s) in Company
15th Jul 20257:02 amRNSBoard and committee composition changes
15th Jul 20257:01 amRNSBarratt Redrow plc ShareBuyback Programme
15th Jul 20257:00 amRNSBarratt Redrow FY25 Trading Update
9th Jul 20257:08 amRNSCMA Consults on Proposed Housebuilder Commitments
4th Jul 20254:56 pmRNSDirector/PDMR Shareholding
1st Jul 20259:35 amRNSTotal Voting Rights
27th Jun 20257:01 amRNSCompletion of £50m Share Buyback programme
27th Jun 20257:00 amRNSTransaction in Own Shares
26th Jun 20257:00 amRNSTransaction in Own Shares
25th Jun 20257:00 amRNSTransaction in Own Shares
24th Jun 20257:00 amRNSTransaction in Own Shares
23rd Jun 20257:00 amRNSTransaction in Own Shares
20th Jun 20257:00 amRNSTransaction in Own Shares
19th Jun 20257:00 amRNSTransaction in Own Shares
18th Jun 20257:00 amRNSTransaction in Own Shares
17th Jun 20257:00 amRNSTransaction in Own Shares
16th Jun 20257:00 amRNSTransaction in Own Shares
13th Jun 20257:00 amRNSTransaction in Own Shares
12th Jun 20257:00 amRNSTransaction in Own Shares
11th Jun 20257:00 amRNSTransaction in Own Shares
10th Jun 20257:00 amRNSTransaction in Own Shares
9th Jun 20257:00 amRNSTransaction in Own Shares
6th Jun 20257:00 amRNSTransaction in Own Shares
5th Jun 20257:00 amRNSTransaction in Own Shares
4th Jun 20257:00 amRNSTransaction in Own Shares
3rd Jun 20257:00 amRNSTransaction in Own Shares
2nd Jun 20259:51 amRNSTotal Voting Rights
2nd Jun 20257:00 amRNSTransaction in Own Shares
30th May 20257:00 amRNSTransaction in Own Shares
29th May 20257:00 amRNSTransaction in Own Shares
28th May 20257:00 amRNSTransaction in Own Shares
27th May 202510:06 amRNSHolding(s) in Company
27th May 20257:00 amRNSTransaction in Own Shares
23rd May 20257:00 amRNSTransaction in Own Shares
22nd May 20257:00 amRNSTransaction in Own Shares
21st May 20257:00 amRNSTransaction in Own Shares
20th May 20257:00 amRNSTransaction in Own Shares
19th May 20257:00 amRNSTransaction in Own Shares
16th May 20257:00 amRNSTransaction in Own Shares
15th May 20257:00 amRNSTransaction in Own Shares
14th May 20252:48 pmRNSReplacement Holding(s) in Company
14th May 202511:28 amRNSHolding(s) in Company
14th May 20257:00 amRNSTransaction in Own Shares
13th May 20257:00 amRNSTransaction in Own Shares
12th May 20257:00 amRNSTransaction in Own Shares
9th May 20257:00 amRNSTransaction in Own Shares
8th May 20257:00 amRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.